Business Wire

Forrester: Generative AI Dominates Top 10 Emerging Technologies In 2023 And Beyond

Share

According to Forrester’s (Nasdaq: FORR) The Top 10 Emerging Technologies In 2023 report, generative AI will begin to deliver significant return on investment for most enterprises in the next two to four years. To fully benefit from generative AI’s applications, firms will need to navigate its risks, including trustworthiness, evolving regulations, and potential intellectual property complications. Despite these risks, generative AI remains a top emerging technology to invest in due to its breadth of impact and ability to accelerate many other top emerging technologies, including autonomous workplace assistants (AWAs) and conversational AI.

Conversational AI, enabled by generative AI, is the second top emerging technology that will deliver the fastest ROI. E-commerce, B2B sales, and customer service functions will see the biggest impacts from conversational AI. AWAs will also deliver near-term benefits for most firms, as they are poised today to take over increasingly complex but repetitive human tasks.

According to Forrester, additional emerging technologies that will offer significant benefits for firms in two to four years include:

  • Decentralized Digital Identity (DDID). DDID will ultimately replace physical proof-of-identity documents, with financial services, government, and education likely to benefit most. Blockchains and zero-knowledge proofs will play a substantial role in this slow transformation.
  • Edge Intelligence. Turning massive data sets produced by computer vision and sensors into real-time action requires more intelligent software running at the edge of business and consumer networks. Customer digital experiences will benefit from edge intelligence the most.
  • Explainable AI (XAI). To be useful, new AI software needs to be trustworthy, which means it must be explainable. While XAI capabilities are still immature, this technology will see its greatest utilization in highly regulated and high-risk use cases in the finance and healthcare sectors.
  • TuringBots. There has been a dramatic acceleration in the number and capability of TuringBots, AI-powered software robots that help developers build applications. In two to four years, a substantial part of enterprise applications could be generated by this technology.

Some emerging technologies that will take at least five years to deliver tangible value for enterprises include:

  • Extended Reality (XR). Only 20% of US online adults are comfortable using virtual reality or augmented reality to consume information, which means that XR will take more years of hardware innovation and consumer adoption. In the short term, enterprises will benefit in the areas of employee training and onboarding.
  • Web3. Despite its promise of a new, more democratic web, Web3 remains a self-referencing ecosystem of financial engineering fraught with risk and scandal. Key technical challenges surrounding Web3 still exist for enterprises, including scaling and security, identity and key management, and privacy.
  • Zero Trust Edge (ZTE). ZTE embeds Zero Trust security principles into software-defined networks that are deployed to offices and physical spaces but controlled centrally via the cloud. The improved security and performance promised by these tools will take more time as security and networking vendor offerings merge and mature.

“While many emerging technologies show great promise, it is imperative for tech leaders to assess whether these technologies can deliver value and if their business can navigate their associated risks,” said Brian Hopkins, Forrester VP, emerging technology portfolio. “This means side-stepping misinformation, mitigating poor decisions driven by a fear of missing out, and narrowing focus from the shiny objects down to the few technologies that have real potential. Firms must also ensure that their time frame for implementing these technologies is commensurate with their overall risk/reward tolerance.”

Resources:

  • Read more about the top emerging technologies that will deliver ROI for enterprises.
  • Read The Top 10 Emerging Technologies In 2023 report to gain insight into maturity trends, business value, important use cases, example innovations, and risks associated with each listed emerging technology (client access required).
  • Learn more about how Forrester arrived at the top 10 emerging technologies for 2023, and register for an upcoming deep-dive webinar on this topic.
  • Register to attend Forrester’s 2023 Technology & Innovation North America Forum.

About Forrester
Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We help leaders across technology, customer experience, digital, marketing, sales, and product functions use customer obsession to accelerate growth. Through Forrester’s proprietary research, consulting, and events, leaders from around the globe are empowered to be bold at work — to navigate change and put their customers at the center of their leadership, strategy, and operations. Our unique insights are grounded in annual surveys of more than 700,000 consumers, business leaders, and technology leaders worldwide; rigorous and objective research methodologies, including Forrester Wave™ evaluations; 100 million real-time feedback votes; and the shared wisdom of our clients. To learn more, visit Forrester.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Naomi Thomas
nathomas@forrester.com
07917 184752

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release

Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i

Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release

Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d

The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release

Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release

4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release

Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye